Omega-3 and Fish Oil: How Much, and Do Supplements Help?

Omega-3 fatty acids are a family of fats that the body uses for cell membranes, the brain and eyes, and the regulation of inflammation. Three of them matter most in the diet: alpha-linolenic acid (ALA), found mainly in plant foods such as walnuts, flaxseed, and canola and soybean oils, and the two long-chain marine forms, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), found mainly in oily fish and in fish-oil supplements. ALA is an essential fatty acid, which means the body cannot make it and has to get it from food.

This guide is general and educational. It explains what omega-3s are and how much the body needs, why food comes before supplements, what the cardiovascular evidence honestly shows after several large recent trials, and the safety points that matter most, including a dose-dependent rise in atrial-fibrillation risk seen with higher-dose supplementation. It does not recommend a personal dose or product, and the cautions below route specific groups to a clinician rather than offering individual medical advice.

The essentials at a glance

• Only ALA has a formal intake target: the Adequate Intake for adults is 1.6 g a day for men and 1.1 g a day for women. There is no separate dietary reference intake for EPA or DHA (NIH Office of Dietary Supplements; confirmed via the Linus Pauling Institute).
• The body converts only a small fraction of plant-derived ALA into the long-chain EPA and especially DHA, which is why oily fish, a direct source of EPA and DHA, is the primary recommended way to get them (NIH ODS; Linus Pauling Institute).
• Across recent large randomized trials, the cardiovascular benefit of omega-3 supplements is modest and mixed: a Cochrane review of 86 trials found little or no effect on overall deaths or cardiovascular events, with only a slight reduction in coronary heart disease (Cochrane, Abdelhamid 2020).
• What is well established is that long-chain omega-3 lowers blood triglycerides, and one high-dose prescription product reduced cardiovascular events in a specific high-risk group, a result that does not transfer to ordinary over-the-counter fish oil (Cochrane; REDUCE-IT, Bhatt 2019).
• Higher-dose marine omega-3 supplementation raises the risk of atrial fibrillation, an irregular heart rhythm, and the risk rises with dose: a meta-analysis found a roughly 12 percent higher risk at 1 g a day or less versus about 49 percent higher at more than 1 g a day (meta-analysis of cardiovascular-outcome RCTs).
• Authorities set safety ceilings: the FDA regards up to 3 g a day of combined EPA and DHA as generally safe, while the EFSA found supplemental intakes up to about 5 g a day raise no safety concern for adults. People on blood thinners or with a heart-rhythm condition should check with a clinician first (FDA, via the Linus Pauling Institute; EFSA).

How much, and the essential one

Of the three dietary omega-3s, only ALA has a formal intake recommendation. The Food and Nutrition Board of the National Academy of Medicine, formerly the Institute of Medicine, set an Adequate Intake for ALA of 1.6 grams a day for adult men and 1.1 grams a day for adult women, as reported by the NIH Office of Dietary Supplements. There is no separate dietary reference intake for EPA or DHA. As the Linus Pauling Institute puts it, after summarizing the same official table, there are no dietary reference intakes for EPA and DHA specifically. ALA is the one labelled essential because the body cannot synthesize it; EPA and DHA can in principle be made from ALA, so no minimum intake was set for them.

The catch is that this internal conversion is inefficient. The body turns only a small fraction of the ALA it eats into EPA, and even less into DHA, the form most concentrated in the brain and eyes. That biochemistry is the practical reason oily fish, which supplies EPA and DHA directly, is treated as the primary recommended source rather than relying on plant ALA alone. Meeting the ALA target is straightforward through everyday plant foods; obtaining a meaningful amount of EPA and DHA realistically means eating oily fish or, where that is not happening, considering a supplement.

Food versus supplements

The consistent message from dietary guidance is food first. Oily fish such as salmon, sardines, mackerel, herring, and trout deliver EPA and DHA in the form the body can use directly, alongside protein and other nutrients, and the Linus Pauling Institute notes the established benefit of eating at least two servings of oily fish a week, which supplies roughly 400 to 500 milligrams of combined EPA and DHA. The food database on this site lists oily fish and their nutrient profiles for anyone planning meals around them. Cochrane reviewers summarize the guideline position plainly: guidance recommends increasing omega-3-rich foods, and sometimes supplementation.

Supplements have a role where dietary intake of fish is low, but they are not a guaranteed shortcut to a cardiovascular benefit. A fish-oil capsule is a reasonable way to raise EPA and DHA intake when someone does not eat fish, much as the vitamin-d-guide treats supplements as a backstop when sunlight and food fall short, and the creatine-monohydrate-guide treats its supplement as a useful but bounded add-on rather than a cure-all. The same realism applies here: a supplement can fill a dietary gap, but as the evidence section below shows, taking fish oil is not a reliable way to prevent heart disease, and at higher doses it carries its own caution.

What the evidence shows

The honest summary of the cardiovascular evidence is modest and mixed, not the clear win that fish-oil marketing once implied. The most extensive assessment to date is the 2020 Cochrane review by Abdelhamid and colleagues, which pooled 86 randomized controlled trials covering 162,796 participants. It found that increasing long-chain omega-3 had little or no effect on all-cause mortality, with a risk ratio of 0.97 graded as high-certainty evidence, and little or no effect on cardiovascular events, with a risk ratio of 0.96, also high-certainty. The reviewers concluded that increasing these fats slightly reduces the risk of coronary heart disease mortality and events, and reduces serum triglycerides, with that lipid effect coming mainly from supplement trials. A slight reduction in one outcome, against no effect on overall deaths or combined cardiovascular events, is a long way from prevention.

That picture is reinforced by individual large trials. In the VITAL trial, published in 2019, marine omega-3 supplementation in 25,871 generally healthy adults did not result in a lower incidence of major cardiovascular events than placebo over a median of more than five years. The plain reading across the body of work is that for most people, an ordinary fish-oil supplement is not a dependable way to lower cardiovascular risk.

There are two genuine, well-supported exceptions worth stating precisely. The first is triglyceride-lowering: long-chain omega-3 reliably lowers blood triglycerides, which is the Cochrane finding above and a recognized clinical use. The second is a single high-dose prescription result. In the REDUCE-IT trial, a prescription drug called icosapent ethyl, a purified form of EPA taken at 4 grams a day, reduced cardiovascular events in patients who had elevated triglycerides despite statin therapy and who already had cardiovascular disease or diabetes with other risk factors. That is an important result, but it is specific: it involved a prescription medication, a high dose, and a high-risk patient group under medical care. It is not evidence that an over-the-counter fish-oil capsule will do the same for a healthy person, and it should not be read that way. A 2017 science advisory from the American Heart Association reflects the same caution, restricting any recommendation for omega-3 supplementation to certain clinical groups rather than the general population.

Safety and the atrial-fibrillation signal

At the doses people typically take, combined EPA and DHA have a reassuring general safety record, and authorities have set explicit ceilings. The FDA regards intakes of up to 3 grams a day of combined EPA and DHA as generally recognized as safe for inclusion in the diet, with up to 2 grams a day of that from dietary supplements, and notes that intakes below 3 grams a day are unlikely to cause clinically significant bleeding. The European Food Safety Authority reached a complementary conclusion, finding that long-term supplemental intakes of combined EPA and DHA up to about 5 grams a day do not raise safety concerns for adults.

Those ceilings come with one specific and important caveat that has emerged from recent trials: higher-dose marine omega-3 supplementation raises the risk of atrial fibrillation, an irregular and often rapid heart rhythm. A meta-analysis of cardiovascular-outcome randomized trials, covering 81,210 patients across seven trials, found that marine omega-3 supplementation was associated with an increased risk of atrial fibrillation, with a pooled hazard ratio of about 1.25. Crucially, the effect was dose-dependent. In trials testing 1 gram a day or less, the increase in risk was modest, with a hazard ratio of about 1.12, roughly a 12 percent relative increase. In trials testing more than 1 gram a day, the hazard ratio rose to about 1.49, roughly a 49 percent relative increase. The high-dose trials in that analysis include products given at 1.8 to 4 grams a day. The practical takeaway is that the convenience-store assumption that more fish oil is automatically better is not supported, and that the dose-dependent atrial-fibrillation signal is the main reason high-dose self-supplementation deserves caution and medical input rather than a casual upward adjustment.

Frequently asked questions

How much omega-3 should I take a day?

Only ALA, the plant form, has a formal target: an Adequate Intake of 1.6 grams a day for adult men and 1.1 grams a day for adult women, per the NIH Office of Dietary Supplements. There is no separate reference intake for the marine forms EPA and DHA, and there is no single universal supplement dose. For most people, eating oily fish meets the need without a capsule. Anyone considering a specific supplement dose, especially a higher one, should discuss it with a clinician rather than self-prescribe.

Does fish oil prevent heart disease?

The evidence does not support saying so. The largest review to date, a 2020 Cochrane analysis of 86 trials and more than 160,000 people, found that omega-3 supplements had little or no effect on overall deaths or cardiovascular events, with only a slight reduction in coronary heart disease. Long-chain omega-3 does reliably lower triglycerides, and one high-dose prescription drug cut events in a specific high-risk group, but for the general public an ordinary fish-oil capsule is not a dependable way to prevent heart disease.

Is it better to eat fish or take fish oil?

Guidance favors food first. Oily fish such as salmon, sardines, and mackerel supply EPA and DHA in a usable form along with other nutrients, and about two servings a week is the commonly cited target. Supplements are a reasonable backstop for people who do not eat fish, but they are not a guaranteed cardiovascular shortcut, so the general recommendation is to prioritize oily fish where possible.

Can you take too much fish oil?

Yes. The FDA regards up to 3 grams a day of combined EPA and DHA as generally safe, and the EFSA found supplemental intakes up to about 5 grams a day raise no safety concern for adults, so there are real ceilings. Beyond general safety, higher-dose supplementation raises the risk of atrial fibrillation in a dose-dependent way, with roughly a 12 percent higher risk at 1 gram a day or less versus about 49 percent at more than 1 gram a day in a meta-analysis of trials. More is not automatically better.

What is the difference between ALA, EPA, and DHA?

ALA, or alpha-linolenic acid, is the plant-based omega-3 found in foods such as walnuts and flaxseed, and it is the essential one the body cannot make. EPA and DHA are the longer-chain marine omega-3s found mainly in oily fish and fish oil. The body can convert some ALA into EPA and DHA, but only a small fraction, which is why direct sources of EPA and DHA, chiefly oily fish, are emphasized for those two.

Who should be careful with fish oil?

People taking anticoagulant or antiplatelet medication should check with a clinician, since omega-3 can affect bleeding. So should people with a heart-rhythm condition or a history of atrial fibrillation, given the dose-dependent rhythm signal, and anyone considering high-dose supplements. People who are pregnant or breastfeeding, or simply unsure whether supplementing suits their situation, should also seek professional input before starting rather than self-prescribing a dose.

References

1. 1Omega-3 Fatty Acids: Fact Sheet for Health Professionals (Adequate Intake for ALA; no DRI for EPA/DHA; FDA and EFSA safety ceilings) · National Institutes of Health, Office of Dietary Supplements. Accessed 2026-06-07.
2. 2Essential Fatty Acids (ALA Adequate Intake table; no DRIs for EPA and DHA; oily fish guidance; FDA 3 g/day GRAS; bleeding/anticoagulant caution) · Linus Pauling Institute, Micronutrient Information Center, Oregon State University. Accessed 2026-06-07.
3. 3Effect of long-term marine Omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis · Circulation, 2021 (PMC9109217). Accessed 2026-06-07.
4. 4Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease (Abdelhamid et al.) · Cochrane Database of Systematic Reviews, 2020; CD003177.pub5 (PMC7049091). Accessed 2026-06-07.
5. 5Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (VITAL trial; Manson et al.) · New England Journal of Medicine, 2019; 380(1):23-32 (PMC6392053). Accessed 2026-06-07.
6. 6Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT trial; Bhatt et al.; prescription icosapent ethyl, 4 g/day) · New England Journal of Medicine, 2019; 380(1):11-22. Accessed 2026-06-07.
7. 7Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association (Siscovick et al.) · Circulation, 2017; 135(15):e867-e884. Accessed 2026-06-07.
8. 8Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) (about 5 g/day raises no safety concern) · EFSA Journal, 2012; 10(7):2815, EFSA NDA Panel. Accessed 2026-06-07.